Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
<h4>Background</h4>Acute Plasmodium vivax malaria is associated with haemolysis, bone marrow suppression, reticulocytopenia, and post-treatment reticulocytosis leading to haemoglobin recovery. Little is known how malaria affects glucose-6-phosphate dehydrogenase (G6PD) activity and wheth...
Guardado en:
Autores principales: | Walter R J Taylor, Saorin Kim, Sim Kheng, Sinoun Muth, Pety Tor, Eva Christophel, Mavuto Mukaka, Alexandra Kerleguer, Lucio Luzzatto, J Kevin Baird, Didier Menard |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1541e051e5744381a2d41c6987f91de7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax
por: Alexandra G. A. Stewart, et al.
Publicado: (2021) -
Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes
por: Andang Miatmoko, et al.
Publicado: (2021) -
Plasmodium vivax malaria endemicity in Indonesia in 2010.
por: Iqbal R F Elyazar, et al.
Publicado: (2012) -
Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles
por: Omwoyo WN, et al.
Publicado: (2014) -
Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations.
por: Yoel Lubell, et al.
Publicado: (2014)